Research Analysts Offer Predictions for MAXIMUS, Inc.’s Q2 2018 Earnings (MMS)

MAXIMUS, Inc. (NYSE:MMS) – Investment analysts at KeyCorp lifted their Q2 2018 earnings per share (EPS) estimates for shares of MAXIMUS in a report issued on Thursday. KeyCorp analyst D. Hooker now expects that the health services provider will earn $0.86 per share for the quarter, up from their prior forecast of $0.79. KeyCorp also issued estimates for MAXIMUS’s Q3 2018 earnings at $0.85 EPS and Q4 2018 earnings at $0.82 EPS.

Several other research analysts have also issued reports on MMS. Canaccord Genuity cut their price target on MAXIMUS from $62.00 to $61.00 and set a “hold” rating on the stock in a report on Friday, November 10th. Zacks Investment Research lowered MAXIMUS from a “hold” rating to a “sell” rating in a report on Tuesday, November 14th. Finally, Maxim Group reiterated a “hold” rating and issued a $69.00 price target (up previously from $66.00) on shares of MAXIMUS in a report on Thursday. One equities research analyst has rated the stock with a sell rating and six have issued a hold rating to the company’s stock. MAXIMUS currently has a consensus rating of “Hold” and an average target price of $67.00.

MAXIMUS (NYSE MMS) opened at $63.79 on Monday. The stock has a market capitalization of $4,160.58, a P/E ratio of 18.99, a price-to-earnings-growth ratio of 2.39 and a beta of 1.21. The company has a quick ratio of 2.08, a current ratio of 2.57 and a debt-to-equity ratio of 0.01. MAXIMUS has a fifty-two week low of $55.18 and a fifty-two week high of $72.71.

MAXIMUS (NYSE:MMS) last announced its quarterly earnings results on Thursday, November 9th. The health services provider reported $0.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.77 by $0.04. The business had revenue of $620.90 million for the quarter, compared to analyst estimates of $606.86 million. MAXIMUS had a return on equity of 22.93% and a net margin of 8.99%.

Several hedge funds have recently bought and sold shares of the company. BlackRock Inc. lifted its holdings in shares of MAXIMUS by 1.6% in the fourth quarter. BlackRock Inc. now owns 6,674,541 shares of the health services provider’s stock valued at $477,763,000 after purchasing an additional 107,376 shares in the last quarter. Victory Capital Management Inc. lifted its holdings in shares of MAXIMUS by 13.3% in the third quarter. Victory Capital Management Inc. now owns 3,514,228 shares of the health services provider’s stock valued at $226,667,000 after purchasing an additional 413,325 shares in the last quarter. State Street Corp lifted its holdings in shares of MAXIMUS by 3.5% in the second quarter. State Street Corp now owns 2,138,049 shares of the health services provider’s stock valued at $133,906,000 after purchasing an additional 71,823 shares in the last quarter. Bank of New York Mellon Corp lifted its holdings in shares of MAXIMUS by 5.6% in the third quarter. Bank of New York Mellon Corp now owns 1,352,606 shares of the health services provider’s stock valued at $87,243,000 after purchasing an additional 71,571 shares in the last quarter. Finally, Brown Advisory Inc. lifted its holdings in shares of MAXIMUS by 1.6% in the third quarter. Brown Advisory Inc. now owns 1,177,964 shares of the health services provider’s stock valued at $75,979,000 after purchasing an additional 18,644 shares in the last quarter. Institutional investors own 96.44% of the company’s stock.

In other news, Director Russell A. Beliveau sold 1,500 shares of the firm’s stock in a transaction that occurred on Wednesday, November 15th. The stock was sold at an average price of $64.30, for a total value of $96,450.00. Following the transaction, the director now owns 40,329 shares in the company, valued at $2,593,154.70. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, General Counsel David Francis sold 1,373 shares of the firm’s stock in a transaction that occurred on Friday, November 17th. The shares were sold at an average price of $65.35, for a total value of $89,725.55. Following the completion of the transaction, the general counsel now owns 13,617 shares in the company, valued at approximately $889,870.95. The disclosure for this sale can be found here. In the last quarter, insiders sold 67,517 shares of company stock worth $4,653,302. Corporate insiders own 3.10% of the company’s stock.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, February 28th. Shareholders of record on Thursday, February 15th will be issued a $0.045 dividend. The ex-dividend date is Wednesday, February 14th. This represents a $0.18 annualized dividend and a yield of 0.28%. MAXIMUS’s payout ratio is currently 5.36%.

ILLEGAL ACTIVITY NOTICE: “Research Analysts Offer Predictions for MAXIMUS, Inc.’s Q2 2018 Earnings (MMS)” was originally published by American Banking News and is the sole property of of American Banking News. If you are reading this piece of content on another domain, it was illegally copied and republished in violation of United States & international trademark and copyright law. The correct version of this piece of content can be read at https://www.americanbankingnews.com/2018/02/12/research-analysts-offer-predictions-for-maximus-inc-s-q2-2018-earnings-mms.html.

About MAXIMUS

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Earnings History and Estimates for MAXIMUS (NYSE:MMS)

Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply